Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension
Patrick Wu, QiPing Feng, V. Eric Kerchberger, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Connecting omics signatures and revealing biological mechanisms with iLINCS
Marcin Pilarczyk, Mehdi Fazel‐Najafabadi, Michal Kouril, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 68
Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic
Wenyi Xu, Jiaqi Yu, Yanan Yang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 36
Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses
Zhenxiang Gao, Theresa Winhusen, Maria P. Gorenflo, et al.
Addiction (2023) Vol. 118, Iss. 7, pp. 1307-1319
Open Access | Times Cited: 24
Drug repurposing in psoriasis, performed by reversal of disease-associated gene expression profiles
Faheem Ahmed, Son Gi Ho, Anupama Samantasinghar, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 6097-6107
Open Access | Times Cited: 33
Overcoming Therapy Resistance in Colon Cancer by Drug Repurposing
Talal El Zarif, Marcel Yibirin, Diana De Oliveira-Gomes, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2105-2105
Open Access | Times Cited: 29
Artificial intelligence-assisted repurposing of lubiprostone alleviates tubulointerstitial fibrosis
Anupama Samantasinghar, Faheem Ahmed, Chethikkattuveli Salih Abdul Rahim, et al.
Translational research (2023) Vol. 262, pp. 75-88
Closed Access | Times Cited: 21
The landscape of the methodology in drug repurposing using human genomic data: a systematic review
Lijuan Wang, Ying Lü, Doudou Li, et al.
Briefings in Bioinformatics (2024) Vol. 25, Iss. 2
Open Access | Times Cited: 6
Genetic imputation of kidney transcriptome, proteome and multi-omics illuminates new blood pressure and hypertension targets
Xiaoguang Xu, Chachrit Khunsriraksakul, James Eales, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Using Transcriptomics and Cell Morphology Data in Drug Discovery: The Long Road to Practice
Lavinia-Lorena Pruteanu, Andreas Bender
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 4, pp. 386-395
Open Access | Times Cited: 14
PharmGWAS: a GWAS-based knowledgebase for drug repurposing
Hongen Kang, Siyu Pan, Shiqi Lin, et al.
Nucleic Acids Research (2023) Vol. 52, Iss. D1, pp. D972-D979
Open Access | Times Cited: 12
RNA Sequencing in Disease Diagnosis
Craig Smail, Stephen B. Montgomery
Annual Review of Genomics and Human Genetics (2024) Vol. 25, Iss. 1, pp. 353-367
Closed Access | Times Cited: 4
Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches
Paul Perco, Matthias Ley, Kinga Kęska‐Izworska, et al.
PROTEOMICS (2025)
Open Access
A Multi-Omics-Empowered Framework for Precision Diagnosis and Treatment of Lysosomal Diseases
Nguyen Thi Hai Yen, Nguyen Tran Nam Tien, Nguyen Quang Thu, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101274-101274
Open Access
New Life of an Old Drug: Caffeine as a Modulator of Antibacterial Activity of Commonly Used Antibiotics
Anna Woziwodzka, Marta Krychowiak‐Masnicka, Grzegorz Gołuński, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 872-872
Open Access | Times Cited: 17
Harnessing the Power of Electronic Health Records and Genomics for Drug Discovery
Kristi Krebs, Lili Milani
The Annual Review of Pharmacology and Toxicology (2023) Vol. 63, Iss. 1, pp. 65-76
Open Access | Times Cited: 10
Transcriptome‐Wide Association Studies (TWAS): Methodologies, Applications, and Challenges
Patrick Evans, Taylor Nagai, Anuar Konkashbaev, et al.
Current Protocols (2024) Vol. 4, Iss. 2
Closed Access | Times Cited: 3
Computational Approaches to Drug Repurposing: Methods, Challenges, and Opportunities
Henry C. Cousins, Gowri Nayar, Russ B. Altman
Annual Review of Biomedical Data Science (2024) Vol. 7, Iss. 1, pp. 15-29
Closed Access | Times Cited: 3
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Ziaurrehman Tanoli, Adrià Fernández‐Torras, Umut Onur Özcan, et al.
Nature Reviews Drug Discovery (2025)
Closed Access
Chemical Composition, Antioxidant, Antibacterial, Antibiofilm, and Cytotoxic Activities of Robusta Coffee Extract (Coffea canephora)
Erma Suryanti, Dwi Retnowati, Muhammad Eka Prastya, et al.
HAYATI Journal of Biosciences (2023) Vol. 30, Iss. 4, pp. 632-642
Open Access | Times Cited: 8
Improving reporting standards for phenotyping algorithm in biomedical research: 5 fundamental dimensions
Wei‐Qi Wei, Robb Rowley, Angela Wood, et al.
Journal of the American Medical Informatics Association (2024) Vol. 31, Iss. 4, pp. 1036-1041
Open Access | Times Cited: 3
Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
Yi Liu, Yanguo Liu, Rongrong Fan, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 7
Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma
Yongsheng Xie, Yingcong Wang, Zhijian Xu, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 11
Computational screening of FDA-approved drugs to identify potential aromatase receptor inhibitors for polycystic ovary syndrome
Fahimeh Koohnavard, Khadijeh Ahmadi, Ebrahim Eftekhar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 15507-15519
Closed Access | Times Cited: 5
Network-based drug repurposing for psychiatric disorders using single-cell genomics
Chirag Gupta, Noah Cohen Kalafut, Declan Clarke, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
New Application of an Old Drug: Anti-Diabetic Properties of Phloroglucinol
Krzysztof Drygalski, Mateusz Maciejczyk, Urszula Miksza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10291-10291
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top